Mark Mallon
Chief Executive Officer bei NeoGenomics Laboratories, Inc.
Profil
Mr. Mark Mallon ist Chief Executive Officer & Director bei NeoGenomics Laboratories, Inc. und Chief Executive Officer & Director bei NeoGenomics, Inc. Er ist Mitglied des Board of Directors bei NeoGenomics Laboratories, Inc. und NeoGenomics, Inc. Herr Mallon war zuvor als Chief Executive Officer & Director bei Ironwood Pharmaceuticals, Inc. beschäftigt, als President bei Astrazeneca China Ltd., als Chief Operating Officer bei Astrazeneca Japan Ltd., als Vice President-Marketing & Sales Operations bei AstraZeneca Pharmaceuticals LP und als Executive Vice President-International bei AstraZeneca Plc. Er war auch im Vorstand der Christiana Care Corp. Er erhielt seinen Bachelor-Abschluss von der University of Pennsylvania und einen MBA von der Wharton School der University of Pennsylvania.
Aktive Positionen von Mark Mallon
Unternehmen | Position | Beginn |
---|---|---|
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | Chief Executive Officer | 19.04.2021 |
Ehemalige bekannte Positionen von Mark Mallon
Unternehmen | Position | Ende |
---|---|---|
NEOGENOMICS, INC. | Chief Executive Officer | 28.03.2022 |
IRONWOOD PHARMACEUTICALS, INC. | Chief Executive Officer | 12.03.2021 |
Astrazeneca China Ltd. | President | 01.11.2011 |
Astrazeneca Japan Ltd.
Astrazeneca Japan Ltd. Medical/Nursing ServicesHealth Services Part of AstraZeneca PLC, Astrazeneca Japan Ltd. is a science-oriented bio and Japanese pharmaceutical company. The private company is based in Ofuka-cho, Japan. Astrazenka mainly focuses on oncology, cardiovascular, metabolism/gastrointestinal diseases, and respiratory diseases to further contribute to the development of patients' health and medical care. The CEO of the company is Stephen Voxstram. | Chief Operating Officer | 01.04.2011 |
AstraZeneca SpA
AstraZeneca SpA Pharmaceuticals: MajorHealth Technology AstraZeneca SpA engages in the production and distribution of pharmaceutical drugs and medicines. Its products specialize in the treatment and therapies for cardiovascular and metabolic, oncology, and respiratory inflammation, and autoimmunity diseases. The company was founded in April 1999 is headquartered in Basiglio, Italy. | President | - |
Ausbildung von Mark Mallon
University of Pennsylvania | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ASTRAZENECA PLC | Health Technology |
NEOGENOMICS, INC. | Health Services |
IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
AstraZeneca SpA
AstraZeneca SpA Pharmaceuticals: MajorHealth Technology AstraZeneca SpA engages in the production and distribution of pharmaceutical drugs and medicines. Its products specialize in the treatment and therapies for cardiovascular and metabolic, oncology, and respiratory inflammation, and autoimmunity diseases. The company was founded in April 1999 is headquartered in Basiglio, Italy. | Health Technology |
Astrazeneca Japan Ltd.
Astrazeneca Japan Ltd. Medical/Nursing ServicesHealth Services Part of AstraZeneca PLC, Astrazeneca Japan Ltd. is a science-oriented bio and Japanese pharmaceutical company. The private company is based in Ofuka-cho, Japan. Astrazenka mainly focuses on oncology, cardiovascular, metabolism/gastrointestinal diseases, and respiratory diseases to further contribute to the development of patients' health and medical care. The CEO of the company is Stephen Voxstram. | Health Services |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | Health Services |
Astrazeneca China Ltd. | |
Christiana Care Corp.
Christiana Care Corp. Hospital/Nursing ManagementHealth Services Christiana Care Corp. operates as a healthcare organization. The private company is based in Middletown, DE. | Health Services |